The Novel Fixed-Dose Combination Will Help In The Management Of Uncontrolled Asthma By Improving Lung Function, Symptom Control, And Reducing Exacerbations. Glenmark Pharmaceuticals Limited (Glenmark) Has Launched The Novel Fixed-Dose Combination (Fdc) Drug-Indacaterol + Mometasone For Patients Suffering From Uncontrolled Asthma In India. The Company Has Launched This Fdc Under The Brand Name Indamet
